Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Oric Pharmaceuticals, Inc. | 41,800 | reported | 16 Jan 2026 | tx 31+303,350−113,228 |
| VivoSim Labs, INC. | 37,000 | reported | 20 Aug 2015 | tx 4+153,000 |
| PMV Pharmaceuticals, Inc. | 33,500 | reported | 05 Jun 2025 | tx 22+213,346−7,800 |
| Enliven Therapeutics, Inc. | 22,647 | reported | 17 Feb 2026 | tx 42+366,010−46,534 |
| Gritstone Oncology, Inc. | 19,000 | reported | 17 Jun 2022 | tx 4+59,070 |
| Metacrine, Inc. | 16,500 | reported | 18 May 2022 | tx 2+33,000 |
| PROTEOSTASIS THERAPEUTICS, INC. | 14,800 | reported | 02 Jun 2021 | tx 4+28,188 |
| Receptos, Inc. | 0 | reported | 27 Aug 2015 | tx 4+26,200−26,200 |
| RayzeBio, Inc. | 0 | reported | 26 Feb 2024 | tx 1−367,446 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 17 Feb 2026 | SALE | Enliven Therapeutics, Inc. | 1,230 | 26.18 USD | |
| 12 Feb 2026 | GRANT_AWARD | Enliven Therapeutics, Inc. | 19,234 | 0.00 USD | deriv |
| 20 Jan 2026 | SALE | Enliven Therapeutics, Inc. | 512 | 26.46 USD | |
| 20 Jan 2026 | SALE | Enliven Therapeutics, Inc. | 718 | 26.96 USD | |
| 16 Jan 2026 | SALE | Oric Pharmaceuticals, Inc. | 3,200 | 12.00 USD | |
| 16 Jan 2026 | SALE | Oric Pharmaceuticals, Inc. | 3,500 | 12.00 USD | |
| 08 Jan 2026 | SALE | Enliven Therapeutics, Inc. | 8,015 | 25.04 USD | |
| 09 Jan 2026 | SALE | Enliven Therapeutics, Inc. | 4,285 | 25.00 USD | |
| 08 Jan 2026 | SALE | Enliven Therapeutics, Inc. | 1,620 | 25.00 USD | |
| 02 Jan 2026 | GRANT_AWARD | Oric Pharmaceuticals, Inc. | 40,000 | 0.00 USD | deriv |
| 03 Oct 2025 | EXERCISE | Oric Pharmaceuticals, Inc. | 31,353 | 1.60 USD | |
| 03 Oct 2025 | EXERCISE | Oric Pharmaceuticals, Inc. | 1,447 | 3.75 USD | |
| 03 Oct 2025 | EXERCISE | Oric Pharmaceuticals, Inc. | 1,447 | 0.00 USD | deriv |
| 03 Oct 2025 | EXERCISE | Oric Pharmaceuticals, Inc. | 13,228 | 0.00 USD | deriv |
| 03 Oct 2025 | EXERCISE | Oric Pharmaceuticals, Inc. | 18,125 | 0.00 USD | deriv |
| 05 Jun 2025 | GRANT_AWARD | PMV Pharmaceuticals, Inc. | 33,500 | 0.00 USD | deriv |
| 06 Feb 2025 | GRANT_AWARD | Enliven Therapeutics, Inc. | 23,014 | 0.00 USD | deriv |
| 02 Jan 2025 | GRANT_AWARD | Oric Pharmaceuticals, Inc. | 35,000 | 0.00 USD | deriv |
| 18 Oct 2024 | SALE | Enliven Therapeutics, Inc. | 753 | 30.00 USD | |
| 18 Oct 2024 | SALE | Enliven Therapeutics, Inc. | 817 | 30.00 USD | |
| 15 Oct 2024 | SALE | Enliven Therapeutics, Inc. | 1,270 | 27.67 USD | |
| 04 Oct 2024 | SALE | Enliven Therapeutics, Inc. | 2,825 | 27.51 USD | |
| 01 Oct 2024 | SALE | Enliven Therapeutics, Inc. | 518 | 27.54 USD | |
| 16 Sept 2024 | SALE | Enliven Therapeutics, Inc. | 1,270 | 22.41 USD | |
| 15 Aug 2024 | SALE | Enliven Therapeutics, Inc. | 650 | 22.82 USD |